About Abraxis BioScience
Abraxis BioScience is a company based in Chicago (United States) founded in 2005 was acquired by Celgene in June 2010. Abraxis BioScience operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Chicago, United States
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abraxis Bioscience, Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Abraxis BioScience
Detailed funding history for Abraxis BioScience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Abraxis BioScience
Abraxis BioScience has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Celgene.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapies for cancer and inflammatory diseases are developed.
|
Locked | Locked | Locked |
Investor details for Abraxis BioScience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Abraxis BioScience
Investment portfolio details for Abraxis BioScience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Abraxis BioScience
Detailed financials for Abraxis BioScience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abraxis Bioscience Comparisons
Peer comparison for Abraxis BioScience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Abraxis BioScience
Abraxis BioScience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of Abraxis BioScience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abraxis Bioscience
Complete news archive for Abraxis BioScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abraxis BioScience
Abraxis BioScience was founded in 2005.
Abraxis BioScience is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Abraxis BioScience was founded in 2005 in Chicago, United States, within the biotechnology sector. Focus was placed on cancer therapeutics through the Nab Technology platform, which enables tumor-targeted delivery of anti-cancer drugs. A key product, Abraxane, a protein-based nanoparticle compound, was created for treating metastatic breast cancer and received FDA approval in 2005. Operations concluded with acquisition by Celgene in 2010.
Abraxis BioScience's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Abraxis BioScience has 1 investor. Key investors include Celgene.